VanitaRArodaMD

Endocrinology • Boston, MA

Diabetes, Lipid Metabolism

Physician

Join to view full profile

Dr. Aroda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Aroda's full profile

Already have an account?

Office
221 Longwood Ave
Boston, MA 02115
Phone+1 617-732-5666

Fax+1 617-525-0436

Education & Training

University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1998 - 2001
University of California San Diego School of MedicineClass of 1998

Certifications & Licensure

CA State Medical License 2000 - Present
MA State Medical License 2017 - 2025
DC State Medical License 2008 - 2018
MD State Medical License 2008 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
Active, not recruiting
Phase 3
Vitamin D and Type 2 Diabetes Study Start of enrollment: 2013 Oct 01
Completed
Not Applicable
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes Start of enrollment: 2020 May 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

583 citations
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabe...
Melanie J Davies, Vanita R Aroda, Billy S Collins, Robert A Gabbay, Jennifer Green
Diabetes Care. 2022-11-01
333 citations
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial*
Andrew J. Ahmann, Matthew Capehorn, Guillaume Charpentier, Francesco Dotta, Elena Henkel
Diabetes Care. 2017-12-15
13 citations
Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme.
Vanita R Aroda, Robert Bauer, Erik Christiansen, Martin Haluzík, Klaus Kallenbach
Diabetes, Obesity & Metabolism. 2022-07-01

Lectures

Overview and Review of the Diabetes Prevention Program and Design of DPPOS
Vanita R. Aroda, MD - 6/16/2014

Press Mentions

Can New Drugs Help Millions of Obese Americans?September 30th, 2024
Treating Hyperglycemia in Type 2 DiabetesOctober 10th, 2022
Type 2 Diabetes Experts: Weight Loss Is (Almost Always) More Important Than Glucose ControlJune 10th, 2022
Join now to see all